Health Care Innovation
Commentary
Say No To Canadian Drug Imports
Lawmakers in the Sunshine State are looking to our northern neighbor to help them reduce drug prices. The Florida House of Representatives recently passed a bill that would allow the importation and sale of prescription drugs from Canada, where prices are generally lower because the government forcibly controls them. Florida isn’t the ...
Health Care
Sally Pipes Share Benefits of Telemedicine With Heartland News
Telemedicine Offers Remedy for Rising Travel and Wait Times By Leo Pusateri Travel and wait times for health care cost patients $89 billion annually, according to an analysis by Altarum, bolstering arguments for the removal of regulatory and legal barriers to the growth of telemedicine. Patients travel an average of ...
Featured
PRI Launches New Center for Medical Economics and Innovation
SAN FRANCISCO – California-based nonpartisan think tank the Pacific Research Institute today announced the launch of a new Center for Medical Economics and Innovation, which will research and advance policies showing how a thriving biomedical and pharmaceutical sector benefits both patients and economic growth. Timely research, analysis and commentary relating ...
Business & Economics
Price Controls Are Never The Answer
Senator Rick Scott (R-FL) has just doubled down on one of the Trump Administration’s unsound ideas. His proposal is disappointing for many reasons, particularly because Alex Azar, Secretary of Health and Human Services, has proposed an alternative reform that, if Congress implemented, would meaningfully improve the affordability of prescription drugs ...
California
March 18 – Free-Market Solutions to California’s Health Care Challenges
In part 1 of a special 4-part series on how free-market ideas can build new, diverse coalitions in California, PRI’s Sally Pipes, Wayne Winegarden, and Henry Miller discuss how proposals like single-payer health care and new mandates on prescription drugs would hurt innovation and how market-based policies can better address ...
Commentary
The FDA has problems — Here are the qualities the next commissioner must have to fix them
The Food and Drug Administration (FDA) is the nation’s most ubiquitous regulatory agency. It oversees a vast array of medical and food products that account for 25 cents of every consumer dollar, with a value of over a trillion dollars annually. And the agency has problems. It’s too risk-averse, bureaucratically ...
Business & Economics
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Commentary
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Commentary
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Commentary
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Say No To Canadian Drug Imports
Lawmakers in the Sunshine State are looking to our northern neighbor to help them reduce drug prices. The Florida House of Representatives recently passed a bill that would allow the importation and sale of prescription drugs from Canada, where prices are generally lower because the government forcibly controls them. Florida isn’t the ...
Sally Pipes Share Benefits of Telemedicine With Heartland News
Telemedicine Offers Remedy for Rising Travel and Wait Times By Leo Pusateri Travel and wait times for health care cost patients $89 billion annually, according to an analysis by Altarum, bolstering arguments for the removal of regulatory and legal barriers to the growth of telemedicine. Patients travel an average of ...
PRI Launches New Center for Medical Economics and Innovation
SAN FRANCISCO – California-based nonpartisan think tank the Pacific Research Institute today announced the launch of a new Center for Medical Economics and Innovation, which will research and advance policies showing how a thriving biomedical and pharmaceutical sector benefits both patients and economic growth. Timely research, analysis and commentary relating ...
Price Controls Are Never The Answer
Senator Rick Scott (R-FL) has just doubled down on one of the Trump Administration’s unsound ideas. His proposal is disappointing for many reasons, particularly because Alex Azar, Secretary of Health and Human Services, has proposed an alternative reform that, if Congress implemented, would meaningfully improve the affordability of prescription drugs ...
March 18 – Free-Market Solutions to California’s Health Care Challenges
In part 1 of a special 4-part series on how free-market ideas can build new, diverse coalitions in California, PRI’s Sally Pipes, Wayne Winegarden, and Henry Miller discuss how proposals like single-payer health care and new mandates on prescription drugs would hurt innovation and how market-based policies can better address ...
The FDA has problems — Here are the qualities the next commissioner must have to fix them
The Food and Drug Administration (FDA) is the nation’s most ubiquitous regulatory agency. It oversees a vast array of medical and food products that account for 25 cents of every consumer dollar, with a value of over a trillion dollars annually. And the agency has problems. It’s too risk-averse, bureaucratically ...
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
